Stock TARA PROTARA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Protara Therapeutics, Inc.

Equities

TARA

US74365U1079

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
2.925 USD -4.10% Intraday chart for Protara Therapeutics, Inc. +10.80% +55.99%
04-22 Oppenheimer Adjusts Protara Therapeutics Price Target to $30 From $26 MT
04-05 Protara Therapeutics, Inc Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition CI

Chart calendar Protara Therapeutics, Inc.

8c809e4788dbf7e8b8b0c3ec1c.-deyUr5M5yE5Phff2-HQQjkXaJG-gNKXgvQv72r206w.wabnAIwNs3lNdGSs9qiWcFhaDODL9qPQ8LYZny-PguKolMcchyCSVWBQQg~c1b03d9a346fef9800684e64082fc912

Upcoming events on Protara Therapeutics, Inc.

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-06-07 12:00 Annual General Meeting
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-03-04 Q4 2024 Earnings Release (Projected)

Past events on Protara Therapeutics, Inc.

2024-03-13 08:00 Q4 2023 Earnings Release
2024-03-06 09:50 TD Cowen Health Care Conference - Fireside Chat
2024-02-14 08:40 Oppenheimer Healthcare Life Sciences Conference - Fireside Chat
2024-02-07 10:30 Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat
2023-11-27 Society of Urologic Oncology Meeting
2023-11-03 08:00 Q3 2023 Earnings Release
2023-09-11 09:30 H.C. Wainwright Global Investment Conference
2023-08-03 08:00 Q2 2023 Earnings Release
2023-06-07 12:00 Annual General Meeting
2023-05-04 08:00 Q1 2023 Earnings Release
2023-03-14 13:20 Oppenheimer Healthcare Conference
2023-03-08 09:50 Cowen Health Care Conference
2023-03-08 08:00 Q4 2022 Earnings Release
2023-02-09 11:20 Guggenheim Oncology Conference
2022-12-02 12:00 Society of Urologic Oncology Meeting - Poster No: 191
2022-11-03 08:00 Q3 2022 Earnings Release
2022-09-12 07:00 H.C. Wainwright Global Investment Conference
2022-08-08 08:00 Interim 2022 Earnings Release
2022-06-08 12:00 Annual General Meeting
2022-06-04 14:15 American Society of Clinical Oncology Meeting - Abstract No. TPS4620

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-34,2
-31,9
-7.36%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-7,83
-23,1
66.06%		-34,4
-34,2
-0.58%		-47,5
-53,4
11.02%		-37,5
-41,4
9.35%		-43,6
-44,8
2.72%
-54,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-34,0
-32,0
-6.32%		-47,3
-51,3
7.83%		-66,0
-37,5
-75.67%		-40,4
-42,2
4.33%
-50,9

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-34,0
-32,0
-6.32%		-47,3
-50,9
7.18%		-66,0
-37,3
-76.9%		-40,4
-41,8
3.35%
-50,6

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-4,70
-3,78
-24.34%		-4,21
-4,16
-1.12%		-5,86
-3,14
-86.82%		-3,57
-3,55
-0.49%
-3,21

Announcement Date11/03/2111/03/2109/03/2208/03/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-10,3
-14,0
26.32%		-10,9
-11,8
7.76%		-8,71
-12,2
28.8%		-7,97
-10,1
21.4%		-9,99
-9,99
-0.02%		-9,73
-11,6
16.38%		-12,1
-11,5
-6.02%		-10,7
-12,8
16.28%		-11,0
-12,2
9.54%
-12,0


-12,8


-13,3


-13,5




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-10,2
-14,2
28.15%		-10,8
-12,0
10%		-8,54
-12,7
32.53%		-7,69
-10,5
26.5%		-39,0
-10,6
-269.35%		-9,05
-12,1
25.4%		-11,3
-11,7
3.4%		-9,86
-12,3
19.84%		-10,2
-12,1
15.18%
-11,9


-12,7


-13,2


-13,2




Net income
Million USD		Released
Forecast
Spread 		-10,2
-13,9
26.3%		-10,8
-11,7
8.38%		-8,54
-12,2
30.25%		-7,69
-10,2
24.31%		-39,0
-9,92
-292.79%		-9,05
-11,6
22.17%		-11,3
-11,3
0.01%		-9,86
-12,4
20.36%		-10,2
-11,6
12.04%
-11,8


-12,6


-13,1


-13,2




EPS
USD		Released
Forecast
Spread 		-0,91
-0,94
3.53%		-0,96
-0,90
-6.27%		-0,80
-0,94
14.59%		-0,68
-0,76
10.13%		-3,46
-0,75
-361.33%		-0,80
-0,88
8.75%		-1,00
-0,88
-14.29%		-0,87
-0,98
11.22%		-0,90
-0,92
1.91%
-0,92


-0,80


-0,77


-0,78




Announcement Date09/03/2205/05/2209/08/2203/11/2208/03/2304/05/2303/08/2303/11/2313/03/24-----

Upcoming sector events for Protara Therapeutics, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 16:05 EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Protara Therapeutics, Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 16:05 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TARA Stock
  4. Calendar Protara Therapeutics, Inc.